LSPN Spring: ‘Fascinating’ UPC is a ‘wake-up call’ for US lawyers

10x Genomics injunction showed the need to take the court ‘really seriously’ says US lawyer | With a focus on efficiency and plaintiff-friendly measures, the UPC's impact on patent valuations and litigation strategies is becoming increasingly apparent, at LSPN Spring.

Already registered?

For multi-user price options, or to check if your company has an existing subscription that we can add you to for FREE, please email Adrian Tapping at atapping@newtonmedia.co.uk

More on this story

Unified Patent Court

WATCH: The Unified Patent Court — two years on the frontline

9 December 2025 Will James and Tim Harris, Osborne Clarke, discuss their experiences litigating life sciences cases before the UPC and share key insights from the court’s early decisions.

Unified Patent Court

Regeneron and CureVac: UPC ‘cannot be ignored’

4 November 2025 Growing clout, powerful remedies, and efficiency are making the UPC a game-changer in global litigation, according to LSPN Europe experts. Tom Phillips reports.

Unified Patent Court

WATCH: UPC update—shaping patent litigation

4 August 2025 Powell Gilbert experts share insights on how the Unified Patent Court is taking shape after two years in operation, in this session from LSPN.

More features

Arnold & Porter loses another regulatory partner to growing rival

CIPA’s outgoing president: UK rejoining the UPC needs ‘support from business’

Merchant & Gould hires 13 attorneys to open new Boston office

Novo Nordisk secures China win ahead of key patent expiration

Edwards v Meril: Inside the UPC’s landmark medtech showdown

Bird & Bird targets Nordic life sciences growth with regulatory hire

Key EU and UK regulatory changes to watch for in 2026

PTAB year in review: A shifting landscape and outlook for 2026

LSPN Spring: ‘Fascinating’ UPC is a ‘wake-up call’ for US lawyers

More on this story

Editor's picks

Editor's picks

More features